Although CTS has shown remarkable biological and pharmacological properties (e.g., anti-inflammatory, antioxidant, and anti-fibrotic) and cardiovascular protective effects (e.g., anti-atherosclerosis), the potential function and underlying molecular mechanisms of CTS in AAA remain to be investigated. This evidence concerns the gene TTR and triple-A syndrome.